Article Information
vol. 45 no. 5 1303-1313
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 16, 2014
- Accepted November 11, 2014
- Published online April 30, 2015.
Article Versions
- previous version (January 22, 2015 - 06:48).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2015
Author Information
- Lewis J. Rubin1,
- Nazzareno Galiè2,
- Friedrich Grimminger3,4,
- Ekkehard Grünig5,
- Marc Humbert6,7,8,
- Zhi-Cheng Jing9,
- Anne Keogh10,
- David Langleben11,
- Arno Fritsch12,
- Flavia Menezes13,
- Neil Davie12 and
- Hossein-Ardeschir Ghofrani3,4,14
- 1Dept of Medicine, University of California, San Diego, La Jolla, California, USA
- 2Dept of Experimental, Diagnostic and Specialty Medicine–DIMES, Bologna University Hospital, Bologna, Italy
- 3University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany
- 4Member of the German Center of Lung Research (DZL)
- 5Centre for Pulmonary Hypertension, Thoraxclinic, University Hospital Heidelberg, Heidelberg, Germany
- 6Université Paris-Sud, Le Kremlin-Bicêtre, France
- 7AP-HP Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- 8INSERM U999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis, Robinson, France
- 9State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
- 10St Vincent's Hospital, Sydney, Australia
- 11Center for Pulmonary Vascular Disease and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Canada
- 12Global Clinical Development, Bayer HealthCare Pharmaceuticals, Wuppertal, Germany
- 13Bayer HealthCare Pharmaceuticals, São Paulo, Brazil
- 14Dept of Medicine, Imperial College London, London, UK
- Lewis J. Rubin, University of California, San Diego, 5550 Caminito Genio, La Jolla, CA 92037, USA. E-mail: ljr{at}lewisrubinmd.com
Article usage
Altmetrics
Vol 45 Issue 5
Table of Contents
Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
